Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
Open | $26.04 |
Close | $26.89 |
Volume / Avg. | 603.17K / 1.15M |
Day Range | 25.96 - 27.00 |
52 Wk Range | 18.16 - 45.58 |
Market Cap | $3.93B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 15.88% |
Days to Cover | 9.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.
Other companies in Immunovant’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
There is no analysis for Immunovant.
Immunovant has a consensus price target of $38.10.
The stock price for Immunovant (NASDAQ: IMVT) is $26.885 last updated July 5, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Immunovant.
Immunovant’s Q1 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.